对177Lu-DOTATATE的辐射安全评估 动脉内受体治疗 (PRRT)

Manoj Kumar Hariram Chauhan1,2, Ashish Kumar Jha3,4, Sneha Mithun3,4

  • 1Department of Nuclear Medicine and Molecular Imaging, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Mumbai, Maharashtra, India.

概括

这项研究测量了干预放射科医生在177Lu-DOTATATE静脉内受体放射性核酸治疗 (PRRT) 期间的辐射暴露. 结果表明,医务人员的辐射剂量在安全范围内,确保了手术安全.